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Abstract
The UK Biobank is a large-scale health resource comprising genetic, environmental
and medical information on approximately 500,000 volunteer participants in the UK,
recruited at ages 40–69 during the years 2006–2010. The project monitors the health
and well-being of its participants. This work demonstrates how these data can be
used to estimate in a semi-parametric fashion the effects of genetic and environmental
risk factors on the hazard functions of various diseases, such as colorectal cancer.
An illness-death model is adopted, which inherently is a semi-competing risks model,
since death can censor the disease, but not vice versa. Using a shared-frailty approach
to account for the dependence between time to disease diagnosis and time to death,
we provide a new illness-death model that assumes Cox models for the marginal
hazard functions. The recruitment procedure used in this study introduces delayed
entry to the data. An additional challenge arising from the recruitment procedure is
that information coming from both prevalent and incident cases must be aggregated.
Lastly, we do not observe any deaths prior to the minimal recruitment age, 40. In
this work we provide an estimation procedure for our new illness-death model that
overcomes all the above challenges.
Keywords: Delayed entry; Frailty model; Left truncation; Random effect; Semi competing
risks;
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1 Introduction
The UK Biobank (UKB) is a large-scale health resource comprising genetic, medical and
environmental information on approximately 500,000 volunteer participants in the UK,
recruited at ages 40–69 during the years 2006–2010. The project monitors the health and
well-being of its participants, thus providing a strong incentive for joining. The participants
have undergone various measurements, provided blood, urine and saliva samples for future
analysis, and have also provided detailed information about themselves. In using these
data to study a given disease, the participants can be classified into three groups: those
already diagnosed with the disease at the time of recuitment (”prevalent” cases), those in
whom the disease is diagosed during follow-up (”incident” cases), and those not diagnosed
with the disesase as of the end of follow-up.
One concern in such a design is delayed entry, since subjects need to live at least up to
the minimum recruitment age in order to participate in the study. Moreover, the existence
of prevalent cases in the data requires special attention due to two reasons: (i) The delayed-
entry correction for those observations must be different to that for the incident cases. (ii)
The data are subject to recall bias – when participants are asked to provide information
regarding their status at the time of disease diagnosis, it is likely that some information
will be reported inaccurately, especially if a long time has passed since then. Death before
the disease constitutes a competing risk to many studied phenotypes, and while death in
general can censor the disease, the disease cannot censor death, hence these settings are
termed “semi-competing risks”. The purpose of this work is to provide appropriate model
and estimation procedure for estimating the survival distribution of a certain disease, such
as colorectal cancer, that properly accommodate semi-competing risks and biased sampling
due to delayed entry.
In this work we focus our attention on colorectal cancer data. Out of 484,918 partici-
3
pants with available genetic and environmental data, there is an overall number of 5,131
colorectal cancer cases in the UKB, of which 2,339 are prevalent and 2,792 are incident.
The number of deaths before having the disease is 12,767, and the number of deaths af-
ter colorectal cancer diagnosis is 1,040. Over the years the number of incident cases will
grow, while the number of prevalent cases will no longer change as recruitment is already
complete.
Under semi-competing risks settings, three stochastic process are typically studied: the
time until disease onset, time until death free of the disease, and time until death after
disease onset. These three processes are sometimes measured on a sojourn time scale,
namely, the disease-death process is not expressed as age of death after disease, but rather
as the amount of time spent in diseased state until death. Since we wish to use a shared
random effect to describe the dependence between the processes, it is easier to work only
with the age-scale and avoid situations with negative dependence (e.g. between age at
diagnosis and the sojourn time in diseased state until death).
Fine et al. (2001) considered a gamma frailty model defined on the upper wedge of the
joint distribution of the events, and supplied a consistent estimator for the parameter of
the gamma distribution, but did not incorporate covariates. Xu et al. (2010) proposed
gamma-frailty illness-death conditional and marginal models, such that the conditional
(on the frailty variate) model is a Cox-type model. If the marginal model is of primary
interest, interpretation of the regression effects might become cumbersome as the marginal
distribution does not take a simple form and also includes the frailty distribution parameter.
Chen (2012) assumed a semi-parametric transformation model for the marginal regressions
and a copula model for the joint distribution. However, it was assumed that occurrence
of the non-terminal event does not alter the distribution of the terminal event, which is
unrealistic in most illness-death scenarios. Extending the copula model in order to account
for the change of distribution is not straightforward. Vakulenko-Lagun & Mandel (2016)
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considered an illness-death model with delayed entry and right-censored data, under a
fully parametric regression framework. However, no dependence structure between the
disease and death times was assumed beyond the observed covariates. Vakulenko-Lagun
et al. (2017) describe a non-parametric inverse probability weighting (IPW) approach for
estimating the joint distribution of disease and death times, subject to right censoring
and delayed entry. This approach does not incorporate covariates. In addition, under the
sampling scheme present in the UKB data, an IPW approach is inapplicable (as will be
explained in Section 3.3). Zhou et al. (2016) described a simple pseudo-likelihood approach
with copulas, aimed at estimating the marginal survival functions and the association
parameter of the copula, but did not account for delayed entry and did not incorporate
covariates. The approach of pseudo-values was presented by Andersen & Klein (2007), in
order to directly estimate the covariate effects on the state probabilities, using a generalized
estimating equations procedure. This approach requires the user to predetermine the time
grid for the state probabilities. In addition, calculation of the pseudo-values for a dataset
as big as the UKB poses a big computational burden.
In illness-death models, age at death after disease diagnosis is left truncated by the age
at diagnosis. In most applications it is unrealistic to assume that the observed covariates
contain all the sources of dependence between age at diagnosis and age at death. Limited
literature exists on Cox regression with dependent left-truncation and right-censored data.
A complete review can be found in Shen (2017). In Section 4.2 we analyze the UKB data
also by including age at diagnosis as a covariate in the model of age at death after diagnosis,
in the spirit of Mackenzie (2012) and Shen (2017). The troubling meaning of these analyses
will be discussed.
None of the aforementioned approaches provides a satisfactory framework for the anal-
ysis of the UKB data. We are seeking a model that can accommodate delayed entry and
a dependence structure between the three described processes. In addition, we want a
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model that is easy to interpret at the population level and can incorporate risk factors
as covariates. Lastly, we would advise against using a fully parametric model, as these
models require more assumptions and are typically less robust, but rather consider a semi-
parametric framework.
The novelty of this work consists of several aspects: (i) Formulation of a new frailty-
based illness-death model with Cox-type marginalized hazards. Under random sampling
and right-censored data, the model parameters are consistently estimated. (ii) Adjusting
the proposed estimators to accommodate delayed entry and the presence of both prevalent
and incident cases, such as in the UKB data. R code for carrying out the data analysis
and the simulations reported in this paper is available at the following Github site: https:
//github.com/nirkeret/frailty-LTRC.
The rest of the paper is organized as follows. Section 2 describes our proposed frailty-
based illness-death model, and the pseudo-likelihood approach for estimating the regression
coefficients and the baseline hazard functions for simple cohort studies with no delayed en-
try. The estimation procedure for delayed-entry data is outlined in Section 3. In Section 4
we present the analysis of colorectal cancer data in the UKB. Section 5 summarizes simu-
lation results, with and without delayed entry. Final remarks are presented in Section 6.
2 Methods: right-censored data, no delayed entry
2.1 Models
Two types of hazard functions are considered: a conditional hazard given the unobserved
frailty variate and the observed time-independent covariates, and a marginalized hazard
function with respect to the frailty variate, namely, the hazard given the time-independent
covariates. The main goal is estimating the illness-death marginalized hazards and survival
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functions. Xu et al. (2010) defined a frailty-based illness death model such that the condi-
tional hazards follow Cox-type models multiplied by a frailty variate, while the marginalized
hazards are functions of the frailty-distribution parameter (Xu et al., 2010, Eq.’s 19–20).
In contrast, we adopt the approach of Glidden & Self (1999), and reformulate the frailty
model so that the marginalized hazard functions obey a specified model, such as the Cox
model, that is free of the frailty-distribution parameter. In the context of this work, it is
preferable that the marginal model be free of the frailty parameter, as its interpretation as
a model corresponding to a randomly selected individual from the population is facilitated
this way. The frailty distribution parameter quantifies the degree of dependence between
the different processes within the same person, so when it is present in a marginal model
it obscures the interpretation of the regression coefficients.
Let T1 and T2 be age at diagnosis and age at death, respectively. Denote the unobserved
frailty by a random variable ω > 0 with a known cumulative distribution function F and
an unknown parameter θ. Let Z be a vector of time-independent covariates. Based on
the notation of Fig. 1, let the conditional hazards of transition from state 1 to either state
k = 2 or 3, given (Z, ω), be
hc1k(t|Z, ω) = lim
∆↘0
1
∆
Pr(t ≤ Tk−1 < t+∆|T1 ≥ t, T2 ≥ t, Z, ω) = ωα1k(t|Z) t > 0 k = 2, 3 .
Let the conditional hazard function of leaving state 2, given (Z, ω), and given the transition
to state 2 occurred at age t1 be defined by
hc23(t|t1, Z, ω) = lim
∆↘0
1
∆
Pr(t ≤ T2 < t+ ∆|T1 = t1, T2 ≥ t, Z, ω) = ωα23(t|Z) t > t1 > 0 .
The non-negative functions αjk, jk = 12, 13, 23, will be determined by the distribution of
the frailty ω and the marginalized hazards presented below. The frailty distribution F
should be chosen such that the hazard models are identifiable.
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The corresponding Cox marginalized hazards are defined by
h1k(t|Z) = lim
∆↘0
1
∆
Pr(t ≤ Tk−1 < t+∆|T1 ≥ t, T2 ≥ t, Z) = h01k(t) exp(γT1kZ) t > 0 k = 2, 3 ,
and
h23(t|t1, Z) = lim
∆↘0
1
∆
Pr(t ≤ T2 < t+∆|T1 = t1, T2 > t, Z) = h023(t) exp(γT23Z) t > t1 > 0 ,
where γjk and h0jk, jk = 12, 13, 23, are the regression coefficient vectors and unspecified
baseline hazard functions, respectively. In h23, disease onset time t1 is not included in the
vector of covariates, but instead the dependence between the time to disease onset and
the time from disease onset to death is captured by the frailty parameter ω. Our goal
is estimating the regression coefficients γjk, the hazards, h0jk, jk = 12, 13, 23, and the
dependence parameter θ.
If one is interested in estimating only γjk and h0jk with jk = 12, 13, the standard
partial likelihood approach can be applied, as in standard applications of Cox models
with competing risks (Kalbfleisch & Prentice, 2011, Ch. 8). Estimation of γ23 and h023
could be more involved since age of death is left-truncated by the age at disease diagnosis.
Under the (unreasonable) assumption that T1 and T2 are conditionally independent given
Z, γ23 and h023 can be easily estimated using a standard partial likelihood approach and
a Breslow estimator, with the usual risk-set correction for left-truncated data (see Section
S8 of Supplementary Material). However, in most applications one cannot observe all the
environmental and genetic effects that fully explain the dependence between T1 and T2,
and the above conditional independence assumption is violated. The standard approach
yields biased estimators of γ23 and h023, as will be demonstrated in the simulation study
(Seciton 4). Instead, we let ω represent the unobserved residual dependence, and assume
that T1 and T2 are independent given (Z, ω). By this, we will be able to circumvent the
dependent left-truncation problem. We provide a unified estimation procedure for all the
parameters of interest, including the dependence parameter.
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As a final step of our new illness-death model presentation, we derive the relationship
between αjk and h0jk, jk = 12, 13, 23, for a given frailty distribution with differentiable
inverse Laplace transform. Denote by φ(s) = E{exp(−sω)} the Laplace transform of
ω, by φ(q)(s) its qth derivative with respect to s, by ψ(s) the inverse Laplace transform,
by ψ(q)(s) its qth derivative, and by ξ(s) the inverse of −φ(1)(s). Also, let H1.(t|Z) =
H12(t|Z)+H13(t|Z), H0jk(t) =
∫ t
0
h0jk(u)du, and Hjk(t|Z) =
∫ t
0
hjk(u|Z)du, jk = 12, 13, 23.
Lemma 1. For t > 0, the relationships between αjk and hjk, jk = 12, 13, 23, are given by
α1k(t|Z) = −h01k(t) exp(γT1kZ)ψ(1)[exp{−H1.(t|Z)}] exp{−H1.(t|Z)} , k = 2, 3 ,
and
α23(t|Z) = −ξ(1)[exp{−H023(t) exp(γT23Z)}] exp{−H023(t) exp(γT23Z)}
exp(γT23Z)h023(t) .
The proof of Lemma 1 is provided in Section S1 of the Supplementary Material.
Generally, a marginalized proportional-hazards model does not yield a conditional pro-
portional hazards model. Importantly, αjk are of the form
αjk(t|Z) = h0jk(t)α∗jk(t|Z) jk = 12, 13, 23 , (1)
where α∗jk can be derived from the LT of the frailty distribution. For example, under the
gamma-frailty model with expectation 1 and variance θ, φ(s) = (1 + θs)−1/θ, and thus
α∗1k(t|Z) = exp(γT1kZ) exp{θH1.(t|Z)} , k = 2, 3 ,
and
α∗23(t|Z) = exp(γT23Z) exp{H23(t|Z)θ/(1 + θ)}/(1 + θ) .
As will be shown in the following section, the representation provided by Eq. (1) plays an
important role in our proposed estimation procedure.
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2.2 Estimation Procedure
Suppose there are n independent subjects. For the ith subject, i = 1, . . . , n, denote by Ci
the censoring time. Let Vi = T1i ∧ T2i ∧ Ci, δ1i = I{T1i ≤ (T2i ∧ Ci)}, so that δ1i equals
1 if the subject was observed to have the disease before being censored or dying. Also let
δ2i = I{T2i ≤ (T1i ∧ Ci)}, so that δ2i equals 1 if the subject died before having the disease
or being censored. Denote by Wi = δ1i(T2i ∧Ci) the age at death or age at censoring after
having the disease, and δ3i = δ1iI(T2i ≤ Ci), which equals 1 if death after the disease was
observed. Then, the observed data consists of (Vi, δ1i, δ2i,Wi, δ3i, Zi), i = 1, . . . , n. The
unobserved frailties ωi, i = 1, . . . , n, are assumed to be independent random variables with
cumulative distribution function F , unknown parameter θ and LT φ such that ψ(1) and ξ(1)
exist.
Let γ = (γT12, γ
T
13, γ
T
23)
T and H0 = (H012, H013, H023). The regression coefficients γ will
be estimated by maximizing a pseudo likelihood, while the cumulative hazard functions H0
will be estimated with Breslow-type estimators. Since the likelihood contains H0, and the
Breslow-type estimator in turn requires γ and θ, a circular dependence is created, which
calls for an iterative algorithm. The proposed estimation procedure is an extension of
Gorfine et al. (2006) for the standard shared-frailty models of correlated failure times. A
discussion that compares the proposed method and that of Gorfine et al. (2006) is provided
in Section S2 of the Supplementary Material.
It is assumed that conditional on Zi and ωi, the censoring times are independent of the
failure times and non-informative for ωi and all the other parameters in the models. In
addition, the frailty variate ωi is assumed to be independent of Zi. Then, the likelihood
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function is proportional to L(γ, θ,H0) =
∏n
i=1 Li, where
Li =
∫
f(Vi, δ1i, δ2i,Wi, δ3i|Zi, ω)dF (ω)
∝ {h012(Vi)α∗12(Vi|Zi)}δ1i{h013(Vi)α∗13(Vi|Zi)}δ2i{h023(Wi)α∗23(Wi|Zi)}δ3i
(−1)δ.iφ(δ.i)(si) , (2)
δ.i =
∑3
j=1 δji, Ajk(t|Z) =
∫ t
0
αjk(u|Z)du, jk = 12, 13, 23, and
si = A12(Vi|Zi) + A13(Vi|Zi) + δ1iA23(Wi|Zi)− δ1iA23(Vi|Zi) . (3)
A detailed explanation of Eq. (21) is provided in Section S3 of the Supplementary Mate-
rial. Finally, for a given estimator of H0, denoted by Ĥ0, the pseudo maximum likelihood
estimator of (γ, θ) is defined to be the arguments which maximize L(γ, θ, Ĥ0).
Estimation of H0 will be done by applying the innovation theorem (Aalen, 1978, Theo-
rem 3.4). We start with defining three counting processes. Let τ be the maximal follow-up
time, and for any t ∈ [0, τ ] and i = 1, . . . , n define the counting processes
Ni(12)(t) = δ1iI(Vi ≤ t) , Ni(13)(t) = δ2iI(Vi ≤ t) and Ni(23)(t) = δ3iI(Wi ≤ t) .
A key assumption is that given the covariates and the frailty variate, Ni(12) and Ni(13) are
independent. Each Ni(jk)(t) has intensity process
Yi(j)(t)αjk(t|Zi)ωi = Yi(j)(t)h0jk(t)α∗jk(t|Zi)ωi jk = 12, 13, 23 i = 1, . . . , n
where Yi(1)(t) = I(Vi ≥ t) and Yi(2)(t) = δ1iI(Vi ≤ t ≤ Wi). The σ-algebra generated by
the observed history up to time t, related to jk = 12, 13, denoted by F (1)t , is defined by
F (1)t = σ{Ni(12)(s), Ni(13)(s), Yi(1)(s), Zi; i = 1, . . . , n; 0 ≤ s ≤ t} .
The σ-algebra related to jk = 23 consists of those observations that were diagnosed with
the disease, namely, those with δ1i = 1 and δ2i = 0, so it is defined by
F (2)t = σ{Vi, Ni(23)(s), Yi(2)(s), Zi; i ∈ {1, . . . , n} such that δ1i = 1, δ2i = 0; 0 ≤ s ≤ t} .
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By the innovation theorem, the stochastic intensity process of Ni(1k)(t), k = 2, 3, with
respect to F (1), is given by
Yi(1)(t)α1k(t|Zi)E(ωi|F (1)t− ) = Yi(1)(t)h01k(t)α∗1k(t|Zi)E(ωi|F (1)t− ) ,
where
E(ωi|F (1)t ) =
∫
ωdF (ω|F (1)t ) =
∫
ωNi(1.)(t)+1 exp[−ω{Ai(1.)(t|Zi)}]dF (ω)∫
ωNi(1.)(t) exp[−ω{Ai(1.)(t|Zi)}]dF (ω)
=
(−1)Ni(1.)(t)+1φNi(1.)(t)+1(Ai(1.)(t|Zi))
(−1)Ni(1.)(t)φNi(1.)(t)(Ai(1.)(t|Zi))
,
Ni(1.)(t) = Ni(12)(t)+Ni(13)(t) and Ai(1.)(t|Zi) = A12(t∧Vi|Zi)+A13(t∧Vi|Zi). For subjects
with δ1i = 1 and δ2i = 0, the stochastic intensity process of Ni(23)(t), with respect to F (2),
is given by
Yi(2)(t)α23(t|Zi)E(ωi|F (2)t− ) = Yi(2)(t)h023(t)α∗23(t|Zi)E(ωi|F (2)t− ) ,
where
E(ωi|F (2)t ) =
∫
ω2+Ni23(t) exp[−ω{Ai.(t|Zi)}]dF (ω)∫
ω1+Ni23(t) exp[−ω{Ai.(t|Zi)}]dF (ω) =
(−1)2+Ni23(t)φ(2+Ni23(t))(Ai.(t|Zi))
(−1)1+Ni23(t)φ(1+Ni23(t))(Ai.(t|Zi)) ,
and Ai.(t|Zi) = Ai(1.)(Vi|Zi) + A23(Wi ∧ t|Zi)− A23(Vi|Zi).
For example, under the gamma frailty model,
E(ωi|F (1)t ) =
θ−1 +Ni(1.)(t)
θ−1 + Ai(1.)(t|Zi) ,
and for subjects with δ1i = 1 and δ2i = 0,
E(ωi|F (2)t ) =
θ−1 + 1 +Ni(23)(t)
θ−1 + Ai.(t|Zi) .
Then, the respective Breslow-type estimators of H0jk(·), jk = 12, 13, 23, are defined as
step functions with jumps at the respective observed failure times. That is,
Ĥ0jk(t) =
∑
s≤t
∆Ĥ0jk(s) , jk = 12, 13, 23 , (4)
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with
∆Ĥ01k(t) =
∑n
i=1 δk−1 iI(Vi = t)∑n
i=1 Yi(1)(t)α̂
∗
1k(t− |Zi)Ê
(
ωi|F (1)t−
) k = 2, 3, (5)
and
∆Ĥ023(t) =
∑n
i=1 δ3iI(Wi = t)∑n
i=1 Yi(2)(t)α̂
∗
23(t− |Zi)Ê
(
ωi|F (2)t−
) , (6)
where in Ê(ωi|F (j)t− ), j = 1, 2, and in α̂∗jk, jk = 12, 13, 23, the unknown parameters are
replaced by their estimators. A detailed description of Âjk, the estimators of Ajk, jk =
12, 13, 23, is provided in Section S4 of the Supplementary Material.
The proposed estimation procedure is summarized as follows.
Step 1. Use standard Cox regression software to obtain initial values of γ̂12, γ̂13 and γ̂23,
by running three separate models, and take θ̂ to a value near independence.
Step 2. Use the current values of (γ̂T , θ̂) and estimate H0jk, jk = 12, 13, 23, by Eq. (4)–(6).
Step 3. Use the current estimate Ĥ0jk, jk = 12, 13, 23, and estimate (γ
T , θ) by maximizing
L(γ, θ, Ĥ0).
Step 4. Iterate between Steps 2 and 3 until convergence is reached.
Let µ = (γT , θ)T , µ̂ = (γ̂T , θ̂)T , µo = (γoT12 , γ
oT
13 , γ
oT
23 , θ
o)T , and Ho0 = (H
o
012, H
o
013, H
o
023),
where the superscript o denotes the respective true value. The following theorem summa-
rizes the asymptotic properties of the proposed estimators. The required technical condi-
tions and a sketch of the proof are provided in Section S5 of the Supplementary Material.
Theorem 1. Under the assumptions listed in Appendix A.2, µ̂ is a consistent estimator
of µ, supt |Ĥ0jk(t) − Ho0jk(t)| = Op(n−1/2), jk = 12, 13, 23,
√
n(µ̂ − µo) is asymptotically
mean-zero multivariate normal, and
√
n{Ĥ0jk(t) − Ho0jk(t)}, jk = 12, 13, 23, converges to
a Gaussian process.
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2.3 Variance Estimation
Deriving the asymptotic or finite-sample variances of the proposed estimators analytically,
is challenging, and is not attempted here. Instead, we advocate the use of the weighted
bootstrap approach (Kosorok et al., 2004). Within each bootstrap sample, a random weight
is assigned to each observation, from a standard exponential distribution. The estimators
of each bootstrap sample are then derived based on logL(b)(γ, θ,H0) =
∑n
i=1 η
(b)
i log(Li),
where η
(b)
i is the weight for subject i of the b-th bootstrap repetition. Likewise, the b-th
bootstrap estimation of the baseline hazard function H012(t) consists of
∆Ĥ
(b)
012(t) =
∑n
i=1 η
(b)
i δ1iI(Vi = t)∑n
i=1 η
(b)
i Yi(1)(t)α̂
∗(b)
12 (t− |Zi)Ê(b)
(
ωi|F (1)t−
) ,
and similarly for H013(t) and H023(t). The weighted bootstrap approach is more suitable
than regular bootstrap in this case, because in highly censored data, the regular bootstrap
could produce samples with a low number of events.
2.4 Computational aspects
We analyze the large-scale UKB dataset. Taking CRC as an example, among the 221,723
men (263,195 women) there were 1,603 (1,189) CRC incident cases, 7,752 (5,015) died
during the follow-up time before having CRC, and out of the 2945 (2,186) prevalent and
incident CRC observations, 668 (372) died. Thus, 212,368 men and 256,991 women were
censored. Our estimation procedure with such a big sample size, is time consuming. Thus,
the following is a simple technique for reducing the sample size with only small efficiency
loss, in the spirit of the basic ideas used in case-cohort designs (Cai & Zeng, 2004). In
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particular, the log-likelihood based on (21) can be written as
n∑
i=1
[∑
j=1,2
δji log{h01 j+1(Vi)α∗1 j+1(Vi|Zi)}+ δ3i log{h023(Wi)α∗23(Wi|Zi)}
]
+
n∑
i=1
I(δ.i > 0) log{(−1)δ.iφ(δ.i)(si)}+
n∑
i=1
I(δ.i = 0) log φ(si) ,
where si is given in (22). In the CRC UKB data, the last sum consists of more than 200,000
observations, within each sex, while most of the information is provided by the events. Let
n0 =
∑n
i=1 I(δ.i = 0). Then, for big datasets with high censoring rates, we recommend
taking a random sub-sample of size n˜ among the censored observations (i.e. those with
δ.i = 0), denoted by C, and the above log-likelihood function is replaced by
n∑
i=1
[∑
j=1,2
δji log{h01 j+1(Vi)α∗1 j+1(Vi|Zi)}+ δ3i log{h023(Wi)α∗23(Wi|Zi)}
]
+
n∑
i=1
I(δ.i > 0) log{(−1)δ.iφ(δ.i)(si)}+ n0
n˜
∑
i∈C
I(δ.i = 0) log φ(si) . (7)
Similarly, the denominators of the cumulative baseline hazard estimators of H01k, k = 2, 3,
are replaced by
n∑
i=1
I(δ.i > 0)Yi(1)(t)α̂
∗
1k(t− |Zi)Ê
(
ωi|F (1)t−
)
+
n0
n˜
∑
i∈C
I(δ.i = 0)Yi(1)(t)α̂
∗
1k(t− |Zi)Ê
(
ωi|F (1)t−
)
. (8)
There is no change in the estimator of H023 since the sub-sampling step has no effect on
the observations involved with this estimator. In summary, the sample consists of all the
observations with at least one observed event and a random sub-sample from the censored
data, where for each observation of the sub-sample a weight of n0/n˜ is assigned; the rest are
assigned with a weight of 1. Cai & Zeng (2004) studied the efficiency loss as a function of
the failure and sampling rates for a simple case-cohort design. For example, with a failure
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rate of 0.01 and a sampling rate n˜/n0 = 0.1, the relative efficiency loss is less than 0.05. In
the following UKB data analysis, n˜ = 20, 000.
3 Methods: right-censored data and delayed entry
3.1 Data and assumptions
In addition to the random variables defined previously, we assume that subject i is recruited
at age Ri, cL ≤ Ri ≤ cU , i = 1, . . . , n, and then followed prospectively until death or
censoring, whichever comes first. In the UKB data, cL = 40 and cU = 69. Thus, the
data consist of n independent observations, each with (Vi, δ1i, δ2i,Wi, δ3i, Zi, Ri). Some
participants had the disease before recruitment, namely Ri > Vi, and these observations
are referred to as prevalent, whereas those who develop the disease after being recruited,
Ri ≤ Vi, are referred to as incident observations. Such a design, known also as length bias
(or left truncation), suffers from sampling bias since only those individuals who live long
enough are observed.
As there are no incident cases below the age of cL, one cannot directly estimate from
the data any of the hazard functions below that age. In this work we focus on CRC. Since
having CRC before age 40 is very rare (Ouakrim et al., 2015), we assume that the probability
of having the disease before age cL is practically zero. Hence, the estimators of the hazard
functions of types jk = 12, 23 are only very slightly biased. Such an assumption should
not be adopted for diseases such as breast cancer, where approximately 7% of diagnoses
are before the age of 40 years (Anders et al., 2009). Thus, our proposed analysis is not
directly applicable for such phenotypes and additional adjustment is required. Likewise, it
is impossible to directly estimate the hazard functions of death before having the disease,
h13(t|Z) and hc13(t|Z, ω), based on the observed data.
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For an illness-death model with delayed entry, there are three principal statistical meth-
ods for inference (Vakulenko-Lagun & Mandel, 2016, and references therein): (i) an uncon-
ditional approach where Ri is considered as a random variable with a known distribution,
and its distribution is included in the likelihood function; (ii) a conditional approach where
the value of the recruitment age, Ri, is conditioned upon; or (iii) a conditional approach
where the entire observed history up to the recruitment age, Ri, is conditioned upon. In
practice, multivariate survival data with delayed entry are most often analyzed using ap-
proach (iii) (Andersen, 1988; Saarela et al., 2009). In an illness-death model with approach
(iii), prevalent individuals are not considered for estimation prior to their entry time, so
they only contribute for estimating the parameters related to transition from diseased state
to death.
Since we have no knowledge or reasonable assumptions on the recruitment distribution
(except for its support), approach (i) is inapplicable. While approach (ii) is more efficient
than (iii) since it utilizes more information, it is more challenging computationally, as it
requires an additional complicated numerical integration. In this section we propose an
estimation procedure adapted for delayed entry, which is based on the procedure of Section
2, and applies approach (iii).
Our proposed estimation procedure for accommodating delayed entry consists of three
modifications: (1) adjusting the likelihood; (2) leveraging external information to estimate
the baseline hazard function of disease-free death, h013, at age t < cL; and (3) adjusting
the hazard functions estimators, H0jk, jk = 12, 13, 23.
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3.2 Adjusted likelihood
The likelihood function based on the observed data given the history up to entry age, Ri,
i = 1, . . . , n, is given by LLT (γ, θ,H0) =
∏
i:Ri<Vi
LLT1i
∏
i:Ri>Vi
LLT2i , where
LLT1i ∝ {h012(Vi)α∗12(Vi|Zi)}δ1i{h013(Vi)α∗13(Vi|Zi)}δ2i{h023(Wi)α∗23(Wi|Zi)}δ3i
(−1)δ.iφ(δ.i)(s11i)/φ(s12i) ,
s11i = A12(Vi|Zi) + A13(Vi|Zi) + δ1iA23(Wi|Zi) − δ1iA23(Vi|Zi) and s12i = A12(Ri|Zi) +
A13(Ri|Zi). Also,
LLT2i ∝ {h023(Wi)α∗23(Wi|Zi)}δ3i(−1)1+δ3iφ(1+δ3i)(s21i)/(−1)φ(1)(s22i) ,
where s21i = A12(Vi|Zi) + A13(Vi|Zi) + A23(Wi|Zi) − A23(Vi|Zi) and s22i = A12(Vi|Zi) +
A13(Vi|Zi) + A23(Ri|Zi) − A23(Vi|Zi). Details on the derivation of the above formulas are
provided in Section S6 of the Supplementary Material.
3.3 Estimating h013(t) for age t < cL
Estimation of the hazard functions under delayed entry is usually done in one of two ap-
proaches: risk-set correction or inverse probability weighting (IPW). In the risk-set correc-
tion approach, prevalent cases cannot contribute to the estimation of h12(t|Z), hc12(t|Z, ω),
h13(t|Z), hc13(t|Z, ω), since only observations that satisfy the condition Ri ≤ Vi ≤ t are
included in the risk set; but they can nevertheless contribute to the estimation of h23(t|Z)
and hc23(t|Z, ω). By contrast, with the IPW approach, prevalent cases can contribute more
in some settings. However, in our setting this approach is inapplicable. The IPW approach
is based on the idea that observations with a small sampling probability are given more
weight so as to rectify their under-representation in the data. Since in the UKB data
only observations who die after the age of 40 can be included in the first place, those who
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died before that age have a sampling probability of 0, and the IPW cannot overcome it.
Therefore, we use the risk-set correction approach.
We propose to estimate H013 for t ≤ cL by leveraging the external information on death
rate in the general population, for example from life tables. We assumed that the marginal
death distribution in the general population approximates sufficiently the marginal death
distribution among individuals free of the disease (a reasonable assumption for diseases that
are rare among individuals of age cL or less), and that there exists a reasonable comparabil-
ity between the general population and the UKB population. The first step is to use general
population data to estimate the marginal hazard h13(t) for t ≤ cL. For our analysis, we have
used data published by the UK Office for National Statistics (https://www.ons.gov.uk).
Proceeding further, the marginal survival function of T13 can be expressed as
S13(t) =
∫
exp{−H013(t−) exp(γT13z)}f(z)dz
and, differentiating with respect to t, the marginal density function is seen to be equal to
f13(t) = S13(t)h13(t) = h013(t)
∫
exp(γT13z) exp{−H013(t−) exp(γT13z)}fZ(z)dz .
Hence, the relationship between h13(t) and h013(t) is
h013(t) = h13(t)
∫
exp{−H013(t−) exp(γT13z)}fZ(z)dz∫
exp(γT13z) exp{−H013(t−) exp(γT13z)}fZ(z)dz
.
Assuming that Z in the cohort is representative of its distribution in the population, then,
given γ̂13 an estimator for h013(t) can be defined as
ĥ013(t) = h13(t)
∑n
i=1 exp{−Ĥ013(t−) exp(γ̂T13zi)}∑n
i=1 exp(γ̂
T
13zi) exp{−Ĥ013(t−) exp(γ̂T13zi)}
, (9)
where ĥ013(t) is estimated successively from 0 to cL at pre-specified equally-spaced grid
of κ points of h13(t), and Ĥ013(t) = cL/κ
∑
u≤t ĥ013(u). If recruitment starts at age cL,
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the estimator of H013 will be based on (9) up to age cL, and then will continue with the
following estimator provided in Section 3.4.
For diseases where the probability of onset before cL is not negligible, such as breast
cancer, a similar approach can be implemented upon the availability of similar disease
incidence information in order to estimate h12 and h
c
12 before cL.
3.4 The adjusted hazard function estimators
For estimating the cumulative hazard functions, the intensity processes above are used
while correcting the risk-sets. Specifically, the respective Breslow-type estimators ofH0jk(·),
jk = 12, 13, 23, are
∆ĤLT012(t) =
∑n
i=1 I(Ri < Vi)δ1iI(Vi = t)∑n
i=1 I(Ri ≤ t ≤ Vi)α̂∗12(t− |Zi)Ê
(
ωi|F (1)t−
) t > 0 , (10)
∆ĤLT013(t) =
∑n
i=1 I(Ri < Vi)δ2iI(Vi = t)∑n
i=1 I(Ri ≤ t ≤ Vi)α̂∗13(t− |Zi)Ê
(
ωi|F (1)t−
) t ≥ cL , (11)
and for t > 0,
∆ĤLT023(t) =
∑n
i=1 δ3iI(Wi = t)∑n
i=1 I(Ri < t)Yi(2)(t)α̂
∗
23(t− |Zi)Ê
(
ωi|F (2)t−
) . (12)
To summarize, the following are the updated Steps 2 and 3 of the proposed estimation
procedure for delayed-entry and right-censored data (Steps 1 and 4 are the same as before):
Step 2˜. Use the current values of (γ̂T , θ̂) and estimate H0jk, jk = 12, 13, 23, by Eq.’s (9)
– (12).
Step 3˜. Use the current estimate Ĥ0jk, jk = 12, 13, 23, and estimate γ and θ by maximiz-
ing LLT (γ, θ, Ĥ0).
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In order to estimate the estimators variance, we suggest using the weighted bootstrap,
as described in Section 2.2.
4 Analysis of UKB Colorectal Cancer (CRC) Data
4.1 Data Processing
The failure time related to CRC, defined to be the age at first invasive colorectal cancer
diagnosis, and death from colorectal cancer, were according to the ICD10 codes (C180,
C182-C189, C19, and C20) or the ICD9 codes (1530–1534, 1536–1541). Cancer of the
appendix or non-invasive (in situ) colorectal cancer cases were excluded, as well as cases of
carcinoid or related tumors (8240–8249) or lymphomas (9590–9729).
To protect the participants’ anonymity, some information, such as exact birth dates,
is suppressed from the dataset. Whenever we could calculate the exact recruitment ages,
we did so, typically for observations who were diagnosed with cancer, or that have died.
We were able to calculate those ages since exact dates of cancer diagnosis and death are
provided in the data, in addition to the exact recruitment dates. Whenever we were
unable to procure the exact recruitment ages, we arbitrarily set the birth dates of those
observations to the 15-th of the month they were reported to be born in.
4.2 Anaylsis Results
We followed the analysis of Jeon et al. (2018), and generated an environmental risk score
(E-score), for lifestyle and environmental risk factors. Specifically, a Cox model with a
delayed-entry adjustment was fitted, with the age at diagnosis of CRC as the outcome and
the recruitment age was used for the risk-set correction. The following well-known CRC
risk factors were included as covariates: sex, height, body mass index, education, smoking
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status, alcohol consumption, ibuprofen use, drugs use, use of post-menopausal hormones
(women only), and physical activity. Prevalent CRC cases were excluded. The results are
provided in Table S1 of the Supplementary Material.
The E-score of each participant, is then defined as a linear combination of all risk factors,
each one weighted by its estimated regression coefficient. The E-scores were subsequently
standardized by performing a quantile transformation based on the E-score empirical cu-
mulative distribution function of the CRC-free observations. The transformed E-scores
were then entered into the following illness-death model as a covariate. The bottom of
Table S1 provides the means and standard deviations of the transformed E-scores, by CRC
status and sex.
Similarly, a genetic risk score (G-score) was derived, based on 72 single-nucleotide poly-
morphisms (SNPs) that have been identified to be associated with CRC by GWAS (Jeon
et al., 2018). Each SNP variable was coded as dosage, which is 0,1, or 2, based on the num-
ber of risk allele copies if the SNP is directly genotyped, and expected number of copies if
it is imputed. The G-score was developed in a similar manner to the E-score. Specifically,
a similar Cox regression model was fitted on the CRC onset age as the outcome, and the
72 SNPs as covariates. The G-score was constructed for each subject as the weighted sum
of the 72 SNPs, with the estimated regression coefficients as weights. A quantile trans-
formation was once again used, based on the G-score empirical cumulative distribution
function of the CRC-free observations. The transformed G-scores were then entered into
our proposed illness-death model as a covariate. A detailed description of the SNPs and
the analysis results are provided in Tables S2–S3 of the Supplementary Material.
Women have a much lower risk of CRC. To allow more precise estimates of the baseline
hazard functions, our proposed illness-death model with delayed-entry adjusted estimation
procedure was applied separately to men and women. The regression coefficient vectors
γ12 and γ13 included G-score and E-score, while γ23 included just the G-score. The E-score
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is not included in the transition model 2 → 3 since this part of the model was estimated
using both prevalent and incident data, and environmental data on the prevalent cases
were expected to be subject to substantial recall bias. We compared our method with
the following Cox models (in which the disease onset age was, in the spirit of Shen, 2017,
included in the model for the transition 2→ 3):
Cox I: Three separate Cox models were fitted. In particular, γ12 and H012 are estimated
based on CRC age at diagnosis as the outcome, age at recruitment is used for risk-set
correction, and other events are treated as independent censoring; γ13 and H013 are
estimated based on age at death before CRC as the outcome, age at recruitment is
used for risk-set correction, other events are treated as independent censoring; γ23
and H023 are estimated based on age at death after CRC as the outcome, and age at
CRC diagnosis and age at recruitment are used for risk-set correction. See Section
S8 of the Supplementary Material, for the partial likelihoods.
Cox II: {γ12, H012, γ13, H013} are estimated as in Cox I. In γ23 the standardized age at diag-
nosis is added as a time-independent covariate, for dealing with the fact that V is a
dependent left-truncation time (Shen, 2017).
Cox III: {γ12, H012, γ13, H013} are estimated as in Cox I. The effect of age of CRC diagnosis is
included using a linear truncated spline with three knots, at the 25%, 50%, and 75%.
The results are presented in Table 1 and Figure 2. As expected, the Cox and the
proposed estimators of {γ12, H012, γ13}, are similar. Under Cox, the baseline hazard function
H013 equals 0 for t ≤ 40, thus the Cox estimator of H013 is smaller than the proposed
estimator. There are substantial differences among the estimators of H023, with extreme
results under Cox with linear truncated spline. The G-score and E-score coefficients are
both significantly greater than zero for the healthy-diseased process. Additionally, it turns
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out that the G-score for CRC does not bear a significant effect on the healthy-death process,
but the corresponding E-score does. This result seems plausible because many CRC-related
risk factors such as smoking status and alcohol consumption, are known to be related to
death in general, and not only to CRC. Also, it is well-known that women have lower risk
for CRC, which might explain why the regression coefficient of the E-score for women in
the healthy-diseased model is much smaller than that of men.
Under the Cox models, the effect of the G-score of the diseased-dead process is null for
men, and negative for women. Namely, among the women, based on the Cox analysis, the
G-score increases CRC risk, but decreases mortality after having the disease. This result is
counter intuitive. In contrast, our proposed analysis suggests that the G-score also tends
to increase the risk of death after having the disease. The dependence parameter among
the event times is approximately 2 (corresponding to a Kendall tau value of approximately
0.5), in both men and women. The large standard error of θ̂ among men (0.480) was driven
by few outliers in the bootstrap sample, while the median absolute deviation was 0.204.
As a result we can deduce that there is a non-negligible dependence between the processes
which was not accounted for through the covariates. Moreover, under the Cox model, the
assumption of independent left-truncated time for h23 is most likely violated and thus yields
biased estimates.
5 Simulation Study
5.1 Data Generation
An extensive simulation study was performed to demonstrate the finite-sample properties
of the proposed estimation procedures, with and without delayed entry.
We assumed a gamma frailty model with expectation 1 and variance θ, and a covariate
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vector ZT = (Z1, Z2, Z3, Z4), each covariate generated independently from Uniform(0, 1),
cL = 0.05 and cU = 0.15. Given a sample of n frailty values and covariate vectors, the
failure times T1 and T2 were generated based on the conditional models h
c
jk, jk = 12, 13, 23.
The marginalized baseline hazard functions were set to be
h012(t) = 0.005I(0 ≤ t < 0.05) + I(t ≥ 0.05)
h013(t) = 0.5I(0 ≤ t < 0.05) + I(0.05 ≤ t ≤ 0.15) + 2I(t ≥ 0.15)
and, h023(t) = I(t ≥ 0.12).
The regression coefficients were chosen to be γT12 = (2, 0.2, 0.05, 0), γ
T
13 = (0.05, 1, 0, 0) and
γT23 = (1, 0, 0, 0.5). Three levels of dependence were studied, θ = 0, 1 or 2, corresponding
to Kendall tau values of approximately 0, 0.35 and 0.5, respectively. The motivation
behind the independence configuration, θ = 0, is for exploring whether using our procedure
results in a substantial efficiency loss compared to the standard partial likelihood approach
corrected for delayed entry.
Using the values of αjk, jk = 12, 13, T1 and T2 were generated by solving for T the
equation exp{−Ajk(T |Z)ω} = U , where U is a value generated from Uniform(0, 1). For
individuals that were diagnosed with the disease, the original T2 values were discarded, and
given T1, Z and ω, a new T2 value was sampled from the respective truncated distribution,
by solving for T the equation exp{−A23(T |Z)ω} = U exp{−A23(T1|Z)ω}. Without delayed
entry, all observations were followed since time 0. Under delayed entry settings, recruitment
ages R were randomly generated from Uniform(cL, cU). For each sample, a large dataset
consisting of {T1, T2, R} was first generated, and from those who were still alive at their
recruitment age R, n observations were randomly sampled. Next, for each observation an
independent censoring time was generated from an exponential distribution with a rate
parameter of 2. In addition, an administrative censoring was imposed at time 0.61. For
θ = 1 about 25% of observations are censored before disease onset or death, and among
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those who were diseased, about 65% are censored before death. For θ = 2 the corresponding
numbers are about 27% and 75%.
5.2 Simulation Results
The following results are based on 100 repetitions for each configuration, and a sample
size of 5000 individuals. The pseudo-likelihood function was maximized with the L-BFGS-
B algorithm, as implemented in the optim function in R. Convergence of the algorithm
was reached once the relative change in the pseudo-log-likelihood between two consecutive
iterations went below 0.0001.
Under the cohort setting with no delayed entry (see Tables S4–S5 of the Supplementary
Material), the proposed and the conventional Cox model yielded unbiased estimators for
the parameters of h12 and h13; however, the conventional Cox model analysis yields biased
parameter estimates in h23, whereas the proposed estimator is unbiased. For example, with
θ = 2, the corresponding estimates of γ23,1 = 1 by Cox and the proposed approach are 0.628
(SE=0.172) and 1.037 (SE=0.181). Also, the true values of H023(t) at t = 0.2, 0.4, 0.6, are
0.08, 0.28 and 0.48, while the corresponding estimates of Cox are 0.056, 0.164 and 0.257 (SEs
are 0.010, 0.026 and 0.039). The respective numbers based on the proposed approach are
0.080, 0.280 and 0.484 (SEs are 0.013, 0.042 and 0.072). Evidently, the proposed approach
performs well in terms of bias, and under θ = 0 the efficiency loss is minimal, if any. These
results highlight the importance of the independent assumption of left truncation, which is
violated in the conventional Cox analysis.
Tables 2–3 summarize the empirical means and standard deviations of θ̂, the regression
coefficients, and the baseline hazard functions at certain time points, under delayed entry.
We contrast between Cox with delayed-entry adjustment by the risk-set approach, when
relevant (see Section S8 of the Supplementary Material for more details) and the proposed
methods. Biased results are displayed in bold.
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Table 2 presents the biased Cox-model estimator of γ23,1 under θ > 0. The estimator
of γ23,4 is practically unbiased as its corresponding covariate is independent of all the
other covariates in the model, while the corresponding covariate of γ23,1 is also affecting the
disease age at onset. Table 3 presents the biased Cox-model results of H013 under any value
of θ, due to also ignoring the fact that no death can be observed before cL = 0.05. Cox
estimators of γ12 and γ13 are unbiased, as expected. In contrast, our proposed estimators
perform well in terms of bias and coverage rates. In addition, we observe that applying our
method under the independence scenario does not result in any substantial efficiency loss.
6 Discussion
We proposed a novel semi-parametric, shared-frailty based method for analysing time-to-
event data, within the illness-death model framework. Our model accounts for delayed
entry and possible dependence between the stochastic processes, and allows for covariates
inclusion. The simulation study shows that the procedure works well in terms of bias and
variance, and does not suffer from a substantial efficiency loss under the independence
scenario.
An alternative estimation procedure, when there is no delayed entry, could be to esti-
mate {γ12, γ13, H012, H013} by a standard partial likelihood approach, estimating H023 based
on Eq. (6), and then plugging these estimates in the likelihood, Eq. (21), for estimating
(θ, γ23), which is a different pseudo likelihood approach. An iterative procedure is still
required, between the estimates of (θ, γ23) and that of H023. Such a procedure might save
some computation time but at the price of some efficiency loss. Under delayed entry, the
estimator of H013 would require a correction in the spirit of Section 3.2. In a future work,
one can compare this approach with our proposed method. Consistency and asymptotic
normality should be worked out from scratch.
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There are a number of directions that this work can be further expanded to. The first
direction is to try and develop a method that uses the prevalent cases for estimating γ12
and H012 as well. In addition, instead of using the same frailty effect for all the three
processes, a more flexible dependence structure can be considered.
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Table 1: UKB Analysis Results: regression coefficient estimates (standard error)
Cox I Cox II Cox III Proposed (20K censored)
221,723 men; 1,603 CRC incident events; 7,752 deaths before CRC;
out of the 2,945 with CRC (prevalent and incident) 668 died (out of them, 462 are incident cases)
θ - - - 1.957 (0.480)
G-score 12 1.358 (0.091) 1.358 (0.091) 1.358 (0.091) 1.333 (0.087)
E-score 12 0.743 (0.089) 0.743 (0.089) 0.743 (0.089) 0.708 (0.095)
G-score 13 0.051 (0.039) 0.051 (0.039) 0.051 (0.039) 0.048 (0.050)
E-score 13 0.785 (0.041) 0.785 (0.041) 0.785 (0.041) 0.749 (0.050)
G-score 23 -0.003 (0.139) -0.072 (0.140) -0.072 (0.139) 0.421 (0.131)
Scaled V - 1.439 (0.097) 1.423 (0.219) -
Spline Q1 - - -0.251 (0.414) -
Spline Q2 - - 0.429 (1.536) -
Spline Q3 - - 0.004 (0.517) -
263,195 women; 1,189 CRC incident events; 5,015 deaths before CRC;
out of the 2,186 with CRC (prevalent and incident) 372 died (out of them, 291 are incident cases)
θ - - - 2.297 (0.161)
G-score 12 1.416 (0.106) 1.416 (0.106) 1.416 (0.106) 1.404 (0.143)
E-score 12 0.260 (0.101) 0.260 (0.101) 0.260 (0.101) 0.248 (0.105)
G-score 13 -0.002 (0.049) -0.002 (0.049) -0.002 (0.049) -0.008 (0.061)
E-score 13 0.650 (0.050) 0.650 (0.050) 0.650 (0.050) 0.632 (0.058)
G-score 23 -0.273 (0.184) -0.399 (0.184) -0.396 (0.184) 0.208 (0.163)
Scaled V - 2.065 (0.158) 2.424 (0.466) -
Spline Q1 - - -0.594 (0.701) -
Spline Q2 - - 0.001 (0.707) -
Spline Q3 - - 0.535 (0.682) -
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Figure 1: Illness-death process.
Supplementary Material
1 Proof of Lemma 1
The following is the proof of Lemma 1. Let Ajk(t|Z) =
∫ t
0
αjk(s|Z)ds, jk = 12, 13, 23.
Then, for t > 0, the relationship between αjk and hjk, can be derived as follows. Denote
by j → k the event of transition from state j to state k. Then, for k = 2, 3,
Pr(1→ k ∈ [t, t+ ∆]|Z) =
∫
Pr(1→ k ∈ [t, t+ ∆]|Z, ω)dF (ω)
.
= ∆
∫
ωα1k(t|Z) exp{−ωA1.(t|Z)}dF (ω)
= −∆φ(1){A1.(t|Z)}α1k(t|Z) , (13)
where A1.(t|Z) = A12(t|Z) + A13(t|Z), φ(s) is the Laplace transform of ω, and φ(q)(s) is
the qth derivative with respect to s. In addition,
Pr(remain in 1 during [0, t]|Z) =
∫
exp{−ωA1.(t|Z)}dF (ω) = φ{A1.(t|Z)} (14)
At the same time,
Pr(remain in 1 during [0, t]|Z) = exp{−H1.(t|Z)} , (15)
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Table 2: Simulation results of regression coefficients and dependence parameter for
right-censored data with delayed entry: Cox is naively corrected for left truncation by
max(V,R) for jk = 23, and properly corrected for left truncation by R for jk =
12, 13. the true parameters values are γ12 = (γ12,1, γ12,2, γ12,3, γ12,4) = (2, 0.2, 0.05, 0),
γ13 = (γ13,1, γ13,2, γ13,3, γ13,4) = (0.05, 1, 0, 0), γ23 = (γ23,1, γ23,2, γ23,3, γ23,4) = (1, 0, 0, 0.5),
n = 5000.
θ θ γ12,1 γ12,2 γ12,3 γ13,1 γ13,2 γ23,1 γ23,4
Cox Corrected for LT
0 mean - 2.007 0.200 0.042 0.058 0.991 1.004 0.505
empirical SD - 0.103 0.084 0.078 0.089 0.093 0.110 0.105
bootstrap SE - 0.093 0.088 0.087 0.097 0.092 0.120 0.107
coverage rate - 0.950 0.960 0.980 0.970 0.940 0.960 0.960
The Proposed Approach
0 mean 0.037 1.995 0.200 0.040 0.056 0.993 1.016 0.491
empirical SD 0.058 0.090 0.091 0.093 0.094 0.091 0.126 0.109
bootstrap SD 0.057 0.095 0.088 0.088 0.098 0.093 0.122 0.105
coverage rate 0.990 0.970 0.930 0.940 0.970 0.960 0.950 0.920
Cox Corrected for LT
1 mean - 2.000 0.198 0.046 0.045 0.993 0.696 0.537
empirical SD - 0.093 0.097 0.089 0.101 0.097 0.140 0.116
estimated SD - 0.092 0.088 0.086 0.097 0.092 0.139 0.127
coverage rate - 0.970 0.920 0.930 0.920 0.950 0.370 0.980
The Proposed Approach
1 mean 1.054 2.005 0.187 0.034 0.041 0.016 1.026 0.524
empirical SD 0.139 0.095 0.093 0.075 0.128 0.111 0.115 0.111
bootstrap SE 0.123 0.090 0.080 0.079 0.118 0.105 0.123 0.108
coverage rate 0.960 0.970 0.910 0.950 0.970 0.970 0.970 0.940
Cox Corrected for LT
2 mean - 1.997 0.214 0.045 0.055 1.002 0.585 0.520
empirical SD - 0.105 0.093 0.084 0.099 0.099 0.162 0.151
bootstrap SD - 0.093 0.088 0.087 0.097 0.092 0.160 0.146
coverage rate - 0.910 0.950 0.960 0.970 0.940 0.280 0.920
The Proposed Approach
2 mean 2.059 1.994 0.203 0.040 0.052 0.993 1.020 0.519
empirical SD 0.165 0.097 0.089 0.075 0.098 0.093 0.171 0.133
estimated SD 0.170 0.096 0.083 0.080 0.097 0.088 0.153 0.128
coverage rate 0.950 0.950 0.930 0.970 0.960 0.950 0.910 0.920
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Table 3: Simulation results of the baseline hazard for right-censored data with de-
layed entry: Cox is naively corrected for left truncation by V for jk = 23, and prop-
erly corrected for left truncation by R for jk = 12, 13, baseline hazard functions at
t = 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, n = 5000. The proposed estimation approach and the naive
Cox model that ignores the frailty effect but corrects for delayed entry. ESD - empirical
SD, CR - empirical coverage rate.
θ 0.1 0.2 0.3 0.4 0.5 0.6 0.1 0.2 0.3 0.4 0.5 0.6
Cox corrected for LT The Proposed Approach
0 H012(t) 0.050 0.150 0.250 0.350 0.450 0.550 0.050 0.150 0.250 0.350 0.450 0.550
mean 0.051 0.151 0.250 0.350 0.451 0.549 0.050 0.151 0.252 0.353 0.455 0.559
ESD 0.007 0.013 0.019 0.027 0.038 0.046 0.006 0.014 0.023 0.030 0.037 0.049
CR 0.980 0.990 0.990 0.960 0.950 0.940 0.940 0.950 0.930 0.960 0.970 0.930
H013(t) 0.075 0.225 0.425 0.625 0.825 1.025 0.075 0.225 0.425 0.625 0.825 1.025
mean 0.051 0.201 0.401 0.602 0.803 1.003 0.078 0.228 0.429 0.630 0.828 1.027
ESD 0.010 0.016 0.029 0.044 0.056 0.078 0.010 0.021 0.037 0.052 0.069 0.091
CR 0.270 0.680 0.830 0.890 0.910 0.920 0.950 0.960 0.920 0.910 0.930 0.940
H023(t) 0.000 0.080 0.180 0.280 0.380 0.480 0.000 0.080 0.180 0.280 0.380 0.480
mean - 0.081 0.181 0.281 0.381 0.482 - 0.081 0.183 0.285 0.389 0.490
ESD - 0.010 0.020 0.028 0.037 0.047 - 0.010 0.021 0.032 0.043 0.056
CR - 0.900 0.930 0.940 0.930 0.940 - 0.960 0.920 0.910 0.900 0.890
1 H012(t) 0.050 0.150 0.250 0.350 0.450 0.550 0.050 0.150 0.250 0.350 0.450 0.550
mean 0.051 0.151 0.253 0.353 0.452 0.553 0.050 0.152 0.252 0.354 0.455 0.560
ESD 0.009 0.017 0.025 0.034 0.042 0.052 0.007 0.018 0.027 0.038 0.047 0.059
CR 0.930 0.900 0.930 0.930 0.930 0.950 0.930 0.960 0.950 0.950 0.960 0.960
H013(t) 0.075 0.225 0.425 0.625 0.825 1.025 0.075 0.225 0.425 0.625 0.825 1.025
mean 0.050 0.203 0.404 0.606 0.807 1.009 0.080 0.233 0.435 0.639 0.844 1.040
ESD 0.009 0.018 0.031 0.045 0.061 0.079 0.011 0.022 0.039 0.059 0.082 0.101
CR 0.220 0.660 0.870 0.900 0.910 0.920 0.950 0.960 0.950 0.950 0.920 0.920
H023(t) 0.000 0.080 0.180 0.280 0.380 0.480 0.000 0.080 0.180 0.280 0.380 0.480
mean - 0.071 0.147 0.218 0.284 0.350 - 0.079 0.178 0.277 0.377 0.477
ESD - 0.011 0.021 0.030 0.037 0.044 - 0.009 0.017 0.026 0.036 0.045
CR - 0.740 0.550 0.390 0.240 0.180 - 0.940 0.930 0.980 0.980 0.980
2 H012(t) 0.050 0.150 0.250 0.350 0.450 0.550 0.050 0.150 0.250 0.350 0.450 0.550
mean 0.050 0.150 0.250 0.350 0.449 0.549 0.051 0.152 0.252 0.353 0.454 0.556
ESD 0.007 0.014 0.022 0.031 0.039 0.047 0.007 0.013 0.021 0.028 0.036 0.045
CR 0.940 0.960 0.930 0.930 0.930 0.960 0.970 0.960 0.950 0.960 0.950 0.970
H013(t) 0.075 0.225 0.425 0.625 0.825 1.025 0.075 0.225 0.425 0.625 0.825 1.025
mean 0.049 0.200 0.400 0.601 0.801 0.999 0.077 0.229 0.431 0.633 0.836 1.038
ESD 0.008 0.018 0.033 0.045 0.060 0.074 0.009 0.019 0.033 0.046 0.060 0.072
CR 0.130 0.590 0.800 0.890 0.940 0.940 0.980 0.980 0.930 0.960 0.950 0.960
H023(t) 0.000 0.080 0.180 0.280 0.380 0.480 0.000 0.080 0.180 0.280 0.380 0.480
mean - 0.058 0.116 0.168 0.217 0.264 - 0.081 0.181 0.281 0.380 0.480
ESD - 0.010 0.017 0.023 0.030 0.034 - 0.013 0.027 0.039 0.052 0.063
CR - 0.330 0.090 0.020 0.000 0.000 - 0.920 0.920 0.940 0.950 0.940
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Male	Female	
Male	Female	 Cox	with	splines	
Figure 2: Baseline hazard functions of UKB colorectal cancer data. First two rows are the
estimators of H012 and H013, respectively, women on the left and men on the right. The
third row is the results of H023.
where H1.(t|Z) = H12(t|Z) + H13(t|Z) and Hjk(t|Z) =
∫ t
0
hjk(u|Z)du. Then, based on the
ratio of (13) and (14) we get the following equations,
h12(t|Z) = h012(t) exp(γT12Z) = −α12(t|Z)
φ(1){A1.(t|Z)}
φ{A1.(t|Z)} , (16)
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and
h13(t|Z) = h013(t) exp(γT13Z) = −α13(t|Z)
φ(1){A1.(t|Z)}
φ{A1.(t|Z)} . (17)
From Eq.s (14) and (15) we get A1.(t|Z) = ψ[exp{−H1.(t|Z)}] and
α1.(t|Z) = −ψ(1)[exp{−H1.(t|Z)}] exp{−H1.(t|Z)}h1.(t|Z) ,
where ψ is the inverse Laplace transform, α1.(t|Z) = α12(t|Z) + α12(t|Z) and h1.(t|Z) =
h12(t|Z) + h12(t|Z). Also, taking the ratio of (16) and (17),
α12(t|Z)
α13(t|Z) =
h12(t|Z)
h13(t|Z) ≡ D(t|Z) .
Then, letting Υ(t|Z) = −ψ(1)[exp{−H1.(t|Z)}] exp{−H1.(t|Z)}, and the above yields
α12(t|Z) = D(t|Z)α13(t|Z) = D(t|Z){Υ(t|Z)h1.(t|Z)− α12(t|Z)} ,
and
α12(t|Z) = D(t|Z)
1 +D(t|Z)Υ(t|Z)h1.(t|Z) .
Finally,
α12(t|Z) = Υ(t|Z)h12(t|Z)
= −h012(t) exp(γT12Z)ψ(1)[exp{−H1.(t|Z)}] exp{−H1.(t|Z)} (18)
and similarly,
α13(t|Z) = Υ(t|Z)h13(t|Z)
= −h013(t) exp(γT13Z)ψ(1)[exp{−H1.(t|Z)}] exp{−H1.(t|Z)} . (19)
Now, for t > t1 > 0, the hazard of transition from disease to death is derived by
Pr(2→ 3 ∈ [t, t+ ∆]|T1 = t1, T2 > t1, Z)
= ∆
∫
ω2α12(t1|Z)α23(t|Z) exp[−ω{A1.(t1|Z) + A23(t|Z)− A23(t1|Z)}]dF (ω)∫
ωα12(t1|Z) exp{−ωA1.(t1|Z)}dF (ω)
= −∆α23(t|Z)φ
(2){A1.(t1|Z) + A23(t|Z)− A23(t1|Z)}
φ(1){A1.(t1|Z)}
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and
Pr(remain in 2 during [t1, t]|T1 = t1, T2 > t1, Z)
=
∫
ωα12(t1|Z) exp[−ω{A1.(t1|Z) + A23(t|Z)− A23(t1|Z)}]dF (ω)∫
ωα12(t1|Z) exp{−ωA1.(t1|Z)}dF (ω)
=
φ(1){A1.(t1|Z) + A23(t|Z)− A23(t1|Z)}
φ(1){A1.(t1|Z)} .
Then,
h23(t|t1, Z) = h023(t) exp(γT23Z)
= −α23(t|Z)φ
(2){A1.(t1|Z) + A23(t|Z)− A23(t1|Z)}
φ(1){A1.(t1|Z) + A23(t|Z)− A23(t1|Z)}
= − ∂
∂t
log{−φ(1)}{A(t1, t|Z)}
where A(t1, t|Z) = A1.(t1|Z) + A23(t|Z)− A23(t1|Z). Therefore,
A(t1, t|Z) = ξ[exp{−H23(t|t1, Z)}] ,
where ξ is the inverse of −φ(1), leading to
A23(t|Z) = ξ[exp{−H23(t|t1, Z)}] + A23(t1|Z)− A1.(t1|Z) .
Finally,
α23(t|Z) = ∂
∂t
ξ[exp{−H23(t|t1, Z)}]
= −ξ(1)[exp{−H023(t) exp(γT23Z)}] exp{−H023(t) exp(γT23Z)}
exp(γT23Z)h023(t) . (20)
2 A short comparison with Gorfine et al. (2006)
Our proposed estimation procedure for the setting of no delayed entry is an extension of
Gorfine et al. (2006). It is useful to clarify the similarity and differences between Gorfine
et al. (2006) and our current work:
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• Gorfine et al. (2006) considered the standard shared-frailty model of clustered data
(e.g. family data) in which the conditional hazard functions given (Z, ω) are defined
by Cox models times the frailty ω, with unspecified baseline hazards. In contrast,
here we focus on the marginal hazard functions integrating over ω, and the condi-
tional hazard functions, given (Z, ω), are dictated by the Cox models imposed on the
marginal hazards and the frailty distribution.
• Gorfine et al. (2006) considered the standard shared-frailty model of clustered data
(e.g. family data), in contrast to the illness-death model considered here. Thus, in
the setting of Gorfine et al. the number of events within a cluster could be as large
as the cluster size. In the current setting, the number of events within a cluster is at
most two.
• Under the shared-frailty setting of Gorfine et al. (2006), the estimation procedure
uses one σ−algebra for the stochastic intensity processes. In our case, since death
after having the disease can occur only after having the disease, two σ−algebras are
required.
3 Details of the likelihood function
It is assumed that conditional on Zi and ωi, the censoring times are independent of the
failure times and non-informative for ωi and all the other parameters in the models. In
addition, the frailty variate ωi is assumed to be independent of Zi. Then, the likelihood
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function is proportional to L(γ, θ,H0) =
∏n
i=1 Li, where
Li =
∫
f(Vi, δ1i, δ2i,Wi, δ3i|Zi, ω)dF (ω)
=
∫
f(Vi, δ1i, δ2i|Zi, ω)f(Wi, δ3i|Vi,Wi > Vi, δ1i = 1, Zi, ω)δ1idF (ω)
∝
∫
{hc12(Vi|Zi, ω)}δ1i{hc13(Vi|Zi, ω)}δ2i{hc23(Wi|Vi, Zi, ω)}δ3i
exp[−ω{A12(Vi|Zi) + A13(Vi|Zi) + δ1iA23(Wi|Zi)− δ1iA23(Vi|Zi)}]dF (ω)
= {h012(Vi)α∗12(Vi|Zi)}δ1i{h013(Vi)α∗13(Vi|Zi)}δ2i{h023(Wi)α∗23(Wi|Zi)}δ3i∫
ωδ.i exp[−ω{A12(Vi|Zi) + A13(Vi|Zi) + δ1iA23(Wi|Zi)− δ1iA23(Vi|Zi)}]dF (ω)
= {h012(Vi)α∗12(Vi|Zi)}δ1i{h013(Vi)α∗13(Vi|Zi)}δ2i{h023(Wi)α∗23(Wi|Zi)}δ3i
(−1)δ.iφ(δ.i)(s)|s=si , (21)
δ.i =
∑3
j=1 δji, and
si = A12(Vi|Zi) + A13(Vi|Zi) + δ1iA23(Wi|Zi)− δ1iA23(Vi|Zi) . (22)
The above likelihood consists of the fact that hc23(t|t1, Z, ω) is defined on the restricted
support t > t1 > 0, so the respective density function is a truncated density at t1.
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4 Details of Âjk under gamma frailty
The estimators of A1k, k = 2, 3, under the gamma frailty settings, are derived in the
following manner:
Â1k(t) =
∫ t
0
ĥ01k(s)α̂
∗
1k(s|Z)ds
=
∫ t
0
ĥ01k(s) exp(γ̂
T
1kZ + θ̂Ĥ1.(s|Z))ds
=
M1.(t)−1∑
i=0
∫ t1.(i+1)
t1.(i)
ĥ01k(s) exp(γ̂
T
1kZ + θ̂Ĥ1.(s|Z))ds
+
∫ t
tM1.(t)
ĥ01k(s) exp(γ̂
T
jkZ + θ̂Ĥ1.(s|Z))ds
where M1.(t) is the ordinal number of the largest observed failure time of the joined times t12
and t13, which is still smaller than t, and t1.(i) is the i’th ordered observed time of the joined
times. Now, the function Ĥ1.(t|Z) is constant between every pair of consecutive observed
failure times, and the function h01k(t) is estimated by the slope of the line connecting two
adjacent values of Ĥ01k. As a result, the entire integrand within each interval is constant,
so Â1k(t) is practically calculated as a sum of constants, each multiplied by its respective
interval length.
A23(t) is estimated in a similar fashion, but only times t23 are taken into account for
the partitioning.
It should be noted that Ajk is estimable just up to the last observed failure time of type
jk, denoted by τjk, so that Âjk(t) is estimated at time t ∧ τjk.
5 Assumptions and main steps of the proof of Theo-
rem 1
The following are the required assumptions for Theorem 1.
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1. The vectors (Vi, δ1i, δ2i,Wi, δ3i, Zi), i = 1, . . . , n, are independent and identically dis-
tributed.
2. Given the time-independent vector of covariates Zi and the frailty variate ωi, the
censoring is independent and non-informative of ωi, γ and H. In addition, ωi is
independent of Zi.
3. There exists a finite maximum follow-up time τ > 0 such that E{Yi(j)(τ)} > 0 for all
i = 1, . . . , n and j = 1, 2.
4. The covariates’ vector Zi is bounded.
5. The parameter µ lies in a compact subset containing an open neighborhood of µo.
6. The baseline hazard functions h0jk, jk = 12, 13, 23, are bounded over [0, τ ] by some
fixed constant.
7. The derivative of the frailty density function, with respect to the frailty parameter,
is absolutely integrable.
8. For each subject, there is a positive probability of having the disease before death.
9. Let U(µ, Ĥ0) be the derivative of L(µ, Ĥ0) with respect to µ. The matrix (∂/∂µ)U(µ, Ĥ)|µ=µo
is invertible with probability going to 1 and n goes to infinity.
Our proposed estimation procedure for the setting of no ascertainment is an extension of
Gorfine et al. (2006). The asymptotic theory of the estimators of Gorfine et al. (2006) is
provided in details by Zucker et al. (2008). Hence the proof of Theorem 1 is based on
Zucker et al. (2008).
To emphasize that the hazards’ estimators are functions of µ, we write Ĥ0jk(t) also as
Ĥ0jk(t, µ), jk = 12, 13, 23, when needed. Almost sure consistency of µ̂ and Ĥ0jk, jk =
12, 13, 23, is based on the following results and the consistency theorem of Foutz (1977):
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(i) For jk = 12, 13, 23, Ĥ0jk(t, µ) converge almost surely to some functions H0jk(t, µ),
uniformly in t and µ.
(ii) The estimating function U(µ,H0(µ)) converges uniformly in µ to E{U(µ,H0(µ))},
where H0(µ) = (Ĥ012(·, µ), Ĥ013(·, µ), Ĥ023(·, µ)).
For the asymptotic normality of µ̂, write
0 = U(µ̂, Ĥ0(µ̂))
= U(µo, Ho0) + {U(µo, Ĥ0(µo))− U(µo, Ho0)}+ {U(µ̂, Ĥ0(µo))− U(µo, Ĥ0(µo))}(23)
and study the right-side of (23). Specifically, U(µo, Ho0) can be written as a sum of inde-
pendent identically distributed random vectors with mean zero. Then, the central limit
theorem yields n1/2U(µo, Ho0) is asymptotically mean-zero multivariate normal.
The mean-zero asymptotic normality of U(µo, Ĥ0(µ
o)) − U(µo, Ho0) is based on some
algebra and the following steps:
(1) A Taylor expansion of U(µo, Ĥ0(µ
o)) about Ho0 .
(2) Approximating Ĥ0jk −Ho0jk, jk = 12, 13, 23, by a martingale representation (See Eq.
(26) of Zucker et al. (2008) and the relevant previous derivations for details).
(3) Plugging the martingale representation of (2) into the expansion of (1).
Taking the first order Taylor expansion of U(µ̂, Ĥ0(µ̂)) about µ
o gives
U(µ̂, Ĥ0(µ
o))− U(µo, Ĥ0(µo)) = D(µo)(µ̂− µo) = op(1)
where D(µ) is the derivative of U(µ, Ĥ0(µ)) with respect to µ.
Combining the above, we conclude that n1/2(µ̂ − µo) is asymptotically zero-mean nor-
mally distributed. The asymptotic distributions of Ĥ0jk, jk = 12, 13, 23, are based on
writing
Ĥ0jk(t, µ̂)−Ho0jk(t) = {Ĥ0jk(t, µ)−Ho0jk(t)}+ {Ĥ0jk(t, µ̂)− Ĥ0jk(t, µ)} (24)
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The weak converges and tightness of {Ĥ0jk(t, µ)−Ho0jk(t)} is derived from the martingale
representation mention in (2) above. Also, by a Taylor expansion we get
Ĥ0jk(t, µ̂)− Ĥ0jk(t, µ) = W (t, µo)T (µ̂− µo) = op(1)
where the limiting function of W (t, µ) is Lipschitz in t. Also, both terms of the right-hand
side of Eq. (24) can be written as sums of independent and identically distributed random
variables. Thus, by the central limit theorem we get asymptotic normality and tightness,
and thus we conclude that n1/2{Ĥ0jk(t, µ̂)−Ho0jk(t)}, jk = 12, 13, 23, converge to Gaussian
processes.
6 The likelihood adjusted to delayed entry
The likelihood function based on the observed data given the history up to truncation times
Ri i = 1, . . . , n, is given by L
LT (γ, θ,H) =
∏
i:Ri<Vi
LLT1i
∏
i:Ri>Vi
LLT2i , where
LLT1i = f(Vi, δ1i, δ2i,Wi, δ3i|Zi, Ri, Vi > Ri)
=
f(Vi, δ1i, δ2i,Wi, δ3i|Zi, Ri)
f(Vi > Ri|Zi, Ri)
=
∫
f(Vi, δ1i, δ2i,Wi, δ3i|Zi, Ri, ω)dF (ω)∫
Sc12(Ri|ω, Zi)Sc13(Ri|ω, Zi)dF (ω)
∝
∫
{hc12(Vi|Zi, ω)}δ1i{hc13(Vi|Zi, ω)}δ2i{hc23(Wi|Vi, Zi, ω)}δ3i
exp[−w{A12(Vi|Zi) + A13(Vi|Zi) + δ1iA23(Wi|Zi)− δ1iA23(Vi|Zi)}]dF (ω)
/
∫
exp[−w{A12(Ri|Zi) + A13(Ri|Zi)}]dF (ω)
= {h012(Vi)α∗12(Vi|Zi)}δ1i{h013(Vi)α∗13(Vi|Zi)}δ2i{h023(Wi)α∗23(Wi|Zi)}δ3i
(−1)δ.iφ(δ.i)(s)|s=s11i/φ(s)|s=s12i ,
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where s11i = A12(Vi|Zi)+Ai13(Vi|Zi)+δ1iA23(Wi|Zi)−δ1iA23(Vi|Zi) and s12i = A12(Ri|Zi)+
A13(Ri|Zi). Also,
LLT2i = f(Vi, δ1i, δ2i,Wi, δ3i|Zi, Ri, Vi, δ1i = 1, δ2i = 0,Wi > Ri)
=
f(Vi, δ1i = 1, δ2i = 0,Wi, δ3i|Zi, Ri)
f(Vi, δ1i = 1, δ2i = 0,Wi > Ri|Zi, Ri)
=
∫
f(Vi, δ1i = 1, δ2i = 0,Wi, δ3i|Zi, Ri, ω)dF (ω)∫
f(Vi, δ1i = 1, δ2i = 0,Wi > Ri|Zi, Ri, ω)dF (ω)
∝
∫
hc12(Vi|Zi, ω){hc23(Wi|Vi, Zi, ω)}δ3i
exp[−ω{A12(Vi|Zi) + A13(Vi|Zi) + A23(Wi|Zi)− A23(Vi|Zi)}]dF (ω)
/
∫
hc12(Vi|Zi, ω) exp[−ω{A12(Vi|Zi) + A13(Vi|Zi) + A23(Ri|Zi)− A23(Vi|Zi)}]dF (ω)
= {h023(Wi)α∗23(Wi|Zi)}δ3i(−1)1+δ3iφ(1+δ3i)(s)|s=s21i/(−1)φ(1)(s)|s=s22i ,
where s21i = A12(Vi|Zi) + A13(Vi|Zi) + A23(Wi|Zi) − A23(Vi|Zi) and s22i = A12(Vi|Zi) +
A13(Vi|Zi) + A23(Ri|Zi)− A23(Vi|Zi).
7 Additional simulation results - no delayed entry
Tables S7–S8 summarize the empirical means and standard deviations of θ̂, the regression
coefficients, and the baseline hazard functions at certain time points, for the simple cohort
setting in which observations are followed since birth (i.e. no delayed entry). To save
computation time, estimated standard error and empirical coverage rates are not included
in the setting of no delayed entry, but included in the setting with delayed entry, presented
in the main text.
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8 Illness-death model while T1 and T2 are independent
given Z
The partial likelihoods for estimating γ12, γ13 and γ23 while conditioning on the entire
observed history up to the recruitment age Ri are given by
n∏
i=1
{
exp(γT12Zi)∑n
j=1 I(Rj ≤ t ≤ Vj) exp(γ12Zj)
}δ1iI(Ri<Vi)
,
n∏
i=1
{
exp(γT13Zi)∑n
j=1 I(Rj ≤ t ≤ Vj) exp(γ13Zj)
}δ2iI(Ri<Vi)
,
and
n∏
i=1
{
exp(γT23Zi)∑n
j=1 I(Rj ≤ t)Yj(2)(Vi) exp(γ23Zj)
}δ3i
.
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Table S4: UKbiobank CRC Analysis: Naive Cox Regression Coefficients of E-score
Risk Factor Coefficient SE Z-value P-value
Family History (yes) 0.271 0.063 4.267 0.000
Height 0.005 0.003 1.814 0.070
BMI 0.016 0.004 3.960 0.000
smoking (yes) 0.168 0.039 4.301 0.000
Alcohol (reference - non or occasional):
light frequent drinker 0.034 0.053 0.635 0.525
very frequent drinker 0.093 0.048 1.949 0.051
Physical activity (yes) -0.010 0.041 -0.255 0.799
Education (reference - prefer not to answer):
lower than high-school -0.241 0.160 -1.513 0.130
high-school -0.240 0.158 -1.516 0.130
higher vocational education -0.243 0.163 -1.490 0.136
college or university graduate -0.304 0.159 -1.910 0.056
Aspirin use 0.066 0.050 1.324 0.186
Ibuprofen drugs use (e.g. Nurofen) -0.092 0.066 -1.395 0.163
Gender and Hormone use (reference - Male):
Female, no hormones use -0.307 0.063 -4.881 0.000
Female, hormone use -0.354 0.064 -5.532 0.000
Quantile-transformed E-score: Mean (SD)
Female diagnosed with CRC 0.531 (0.289)
Female CRC free 0.500 (0.289)
Male diagnosed with CRC 0.588 (0.278)
Male CRC free 0.500 (0.289)
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Table S5: UKbiobank CRC Analysis: Naive Cox Regression Coefficients of G-score
Chromosome and SNP Names RS Name Position Coefficient SE Z value P-value
1:22587728 T/C rs72647484 22587728 -0.151 0.050 -3.012 0.003
1:183081194 A/C rs10911251 183081194 -0.091 0.027 -3.353 0.001
1:222045446 G/T rs6691170 222045446 0.068 0.028 2.464 0.014
2:192587204 T/C rs11903757 192587204 0.008 0.036 0.224 0.823
2:219154781 G/A rs992157 219154781 0.071 0.027 2.608 0.009
3:37034946 G/A rs1800734 37034946 0.005 0.033 0.165 0.869
3:40924962 T/A rs35360328 40924962 0.088 0.037 2.379 0.017
3:66442435 C/G rs812481 66442435 -0.033 0.027 -1.240 0.215
3:169492101 C/T rs10936599 169492101 -0.035 0.031 -1.116 0.264
3:169950156 T/C rs185423955 169950156 1.363 0.502 2.717 0.007
4:94943383 C/T rs1370821 94943383 0.074 0.027 2.713 0.007
4:149748994 T/C rs60745952 149748994 0.000 0.038 -0.005 0.996
4:163333405 T/A rs35509282 163333405 -0.022 0.043 -0.507 0.612
5:1286516 C/A rs2736100 1286516 0.017 0.038 0.439 0.661
5:1296486 A/G rs2735940 1296486 0.085 0.038 2.234 0.026
5:40282106 G/C rs1445012 40282106 0.128 0.029 4.406 0.000
5:96133795 G/A rs142227741 96133795 0.049 0.170 0.286 0.775
5:112175211 T/A rs1801155 112175211 -0.142 0.627 -0.227 0.820
5:134499092 C/A rs647161 134499092 0.047 0.029 1.654 0.098
6:35528204 T/C rs144037597 35528204 -0.064 0.042 -1.526 0.127
6:36622900 C/A rs1321311 36622900 0.004 0.031 0.140 0.889
6:41692812 G/A rs4711689 41692812 0.047 0.027 1.720 0.086
6:55714314 C/T rs62404968 55714314 -0.038 0.031 -1.218 0.223
6:117822993 C/T rs4946260 117822993 0.037 0.027 1.366 0.172
6:160840252 G/T rs7758229 160840252 0.011 0.028 0.400 0.689
8:117624093 T/C rs2450115 117624093 -0.035 0.040 -0.877 0.380
8:117630683 A/C rs16892766 117630683 0.178 0.046 3.837 0.000
8:117647788 G/A rs6469656 117647788 -0.007 0.047 -0.147 0.883
8:128413305 G/T rs6983267 128413305 -0.187 0.027 -6.952 0.000
9:6365683 A/C rs719725 6365683 0.033 0.028 1.216 0.224
10:8701219 G/A rs10795668 8701219 -0.127 0.029 -4.346 0.000
10:16997266 G/T rs10904849 16997266 0.008 0.029 0.284 0.776
10:52645424 C/T rs10994860 52645424 -0.085 0.036 -2.362 0.018
10:80819132 A/G rs704017 80819132 0.110 0.027 4.036 0.000
10:101345366 C/T rs1035209 101345366 0.090 0.033 2.729 0.006
10:104595248 G/A rs4919687 104595248 0.013 0.029 0.441 0.659
10:114280702 T/C rs12241008 114280702 0.121 0.042 2.856 0.004
10:114726843 G/A rs11196172 114726843 0.088 0.038 2.305 0.021
11:61552680 G/T rs174537 61552680 -0.034 0.028 -1.190 0.234
11:61982418 G/A rs60892987 61982418 0.009 0.033 0.265 0.79149
Table S6: UKbiobank CRC Analysis: Naive Cox Regression Coefficients of G-score - Con-
tinued
Chromosome and SNP Names RS Name Position Coefficient SE Z value P-value
11:74345550 T/G rs3824999 74345550 0.087 0.027 3.243 0.001
11:111171709 C/A rs3802842 111171709 -0.090 0.029 -3.132 0.002
12:4368352 T/C rs10774214 4368352 -0.043 0.028 -1.575 0.115
12:4388271 C/T rs3217810 4388271 0.033 0.042 0.786 0.432
12:6385727 C/T rs10849432 6385727 0.044 0.043 1.013 0.311
12:6982162 C/T rs11064437 6982162 -0.188 0.192 -0.978 0.328
12:51155663 C/T rs11169552 51155663 -0.051 0.031 -1.659 0.097
12:111884608 T/C rs3184504 111884608 0.079 0.027 2.969 0.003
12:115888504 G/A rs12822984 115888504 0.029 0.027 1.059 0.290
12:117747590 T/G rs73208120 117747590 0.031 0.047 0.660 0.509
13:34093518 C/G rs10161980 34093518 -0.008 0.028 -0.290 0.771
14:54410919 T/C rs4444235 54410919 0.076 0.027 2.826 0.005
14:54560018 T/C rs1957636 54560018 -0.050 0.027 -1.858 0.063
15:32993111 C/T rs16969681 32993111 0.179 0.044 4.025 0.000
15:33004247 G/A rs11632715 33004247 0.066 0.027 2.444 0.015
16:9297812 G/A rs79900961 9297812 -0.016 0.092 -0.174 0.862
16:68820946 G/A rs9929218 68820946 -0.071 0.030 -2.368 0.018
16:86340448 G/C rs2696839 86340448 -0.047 0.027 -1.755 0.079
16:86695720 G/C rs16941835 86695720 0.031 0.033 0.928 0.353
17:800593 T/C rs12603526 800593 0.133 0.084 1.591 0.112
18:46450976 A/G rs7229639 46450976 0.018 0.047 0.390 0.697
18:46453463 T/C rs4939827 46453463 -0.154 0.028 -5.458 0.000
19:33532300 C/T rs10411210 33532300 -0.131 0.047 -2.790 0.005
19:41860296 A/G rs1800469 41860296 0.118 0.030 3.922 0.000
19:46321507 A/G rs56848936 46321507 -0.628 0.717 -0.876 0.381
20:6404281 C/A rs961253 6404281 0.026 0.028 0.934 0.350
20:6699595 T/G rs4813802 6699595 0.084 0.028 3.030 0.002
20:7812350 T/C rs2423279 7812350 0.098 0.031 3.218 0.001
20:33173883 C/T rs2295444 33173883 -0.030 0.027 -1.104 0.270
20:47340117 A/G rs6066825 47340117 -0.178 0.029 -6.250 0.000
20:49057488 C/T rs1810502 49057488 -0.094 0.027 -3.468 0.001
20:60921044 T/C rs4925386 60921044 0.114 0.029 3.910 0.000
Quantile-transformed G-score: Mean (SD)
Female diagnosed with CRC 0.603 (0.280)
Female CRC free 0.500 (0.289)
Male diagnosed with CRC 0.602 (0.280)
Male CRC free 0.500 (0.289)
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Table S7: Simulation results of regression coefficients and dependence parameters for
right-censored data with no delayed entry: The true parameters values are γ12 =
(γ12,1, γ12,2, γ12,3, γ12,4) = (2, 0.2, 0.05, 0), γ13 = (γ13,1, γ13,2, γ13,3, γ13,4) = (0.05, 1, 0, 0), and
γ23 = (γ23,1, γ23,2, γ23,3, γ23,4) = (1, 0, 0, 0.5). Cox is naively corrected for left truncation by
V for jk = 23. To save computation time, estimated standard error and empirical coverage
rates are not included in the setting of no delayed entry, but included in the setting with
delayed entry, presented in the main text.
θ θ γ12,1 γ12,2 γ12,3 γ13,1 γ13,2 γ23,1 γ23,4
Cox Corrected for LT
0 mean - 2.008 0.196 0.041 0.049 1.003 0.986 0.498
empirical SD - 0.085 0.076 0.076 0.095 0.088 0.145 0.131
estimated SE - 0.088 0.083 0.082 0.092 0.089 0.140 0.125
coverage rate - 0.940 0.960 0.960 0.900 0.970 0.960 0.920
The Proposed Approach
0 mean 0.050 1.987 0.194 0.038 0.043 0.993 1.042 0.495
empirical SD 0.078 0.098 0.089 0.079 0.094 0.089 0.140 0.124
Cox Corrected for LT
1 mean - 2.007 0.187 0.055 0.042 0.996 0.747 0.495
empirical SD - 0.084 0.090 0.088 0.093 0.085 0.149 0.153
estimated SE - 0.088 0.083 0.082 0.092 0.089 0.163 0.148
coverage rate - 0.960 0.900 0.930 0.950 0.960 0.660 0.910
The Proposed Approach
1 mean 1.073 1.981 0.189 0.041 0.057 0.972 1.033 0.504
empirical SD 0.131 0.090 0.079 0.083 0.091 0.087 0.153 0.146
Cox Corrected for LT
2 mean - 1.995 0.203 0.057 0.046 1.002 0.628 0.522
empirical SD - 0.078 0.080 0.073 0.099 0.095 0.172 0.151
estimated SE - 0.088 0.083 0.082 0.092 0.089 0.187 0.171
coverage rate - 0.970 0.940 0.980 0.930 0.920 0.440 0.940
The Proposed Approach
2 mean 2.087 1.969 0.180 0.034 0.041 0.991 1.037 0.503
empirical SD 0.188 0.092 0.075 0.072 0.087 0.086 0.181 0.150
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Table S8: Simulation results of baseline hazard function estimators for right-censored data
with no delayed entry: baseline hazard functions at t = 0.1, 0.2, 0.3, 0.4, 0.5, 0.6. Cox is
naively corrected for left truncation by V for jk = 23. ESD - empirical SD, CR - empirical
coverage rate. To save computation time, estimated standard error and empirical coverage
rates are not included in the setting of no delayed entry, but included in the setting with
delayed entry, presented in the main text.
θ 0.1 0.2 0.3 0.4 0.5 0.6 0.1 0.2 0.3 0.4 0.5 0.6
Cox corrected for LT The Proposed Approach
0 H012(t) 0.050 0.150 0.250 0.350 0.450 0.550 0.050 0.150 0.250 0.350 0.450 0.550
mean 0.050 0.151 0.252 0.353 0.453 0.551 0.051 0.153 0.256 0.358 0.457 0.558
ESD 0.004 0.012 0.020 0.027 0.038 0.045 0.006 0.017 0.028 0.037 0.047 0.056
CR 0.980 0.980 0.980 0.970 0.950 0.970 * * * * * *
H013(t) 0.075 0.225 0.425 0.625 0.825 1.025 0.075 0.225 0.425 0.625 0.825 1.025
mean 0.075 0.225 0.426 0.626 0.822 1.021 0.075 0.227 0.429 0.633 0.835 1.042
ESD 0.007 0.017 0.031 0.044 0.057 0.072 0.006 0.017 0.032 0.047 0.058 0.078
CR 0.930 0.940 0.970 0.970 0.960 0.970 * * * * * *
H023(t) 0.000 0.080 0.180 0.280 0.380 0.480 0.000 0.080 0.180 0.280 0.380 0.480
mean - 0.082 0.183 0.285 0.385 0.486 - 0.080 0.181 0.282 0.384 0.488
ESD - 0.012 0.023 0.036 0.047 0.059 - 0.011 0.020 0.032 0.042 0.055
CR - 0.920 0.940 0.950 0.940 0.930 * * * * * *
1 H012(t) 0.050 0.150 0.250 0.350 0.450 0.550 0.050 0.150 0.250 0.350 0.450 0.550
mean 0.050 0.150 0.251 0.351 0.452 0.558 0.052 0.154 0.256 0.361 0.461 0.567
ESD 0.004 0.012 0.019 0.026 0.038 0.048 0.006 0.015 0.024 0.035 0.048 0.062
CR 0.980 0.970 0.950 0.970 0.960 0.970 * * * * * *
H013(t) 0.075 0.225 0.425 0.625 0.825 1.025 0.075 0.225 0.425 0.625 0.825 1.025
mean 0.076 0.227 0.430 0.632 0.837 1.033 0.076 0.228 0.431 0.633 0.836 1.038
ESD 0.007 0.019 0.032 0.048 0.062 0.077 0.006 0.017 0.033 0.046 0.064 0.090
CR 0.940 0.940 0.950 0.940 0.940 0.950 * * * * * *
H023(t) 0.000 0.080 0.180 0.280 0.380 0.480 0.000 0.080 0.180 0.280 0.380 0.480
mean - 0.070 0.145 0.217 0.283 0.347 - 0.080 0.180 0.282 0.382 0.484
ESD - 0.010 0.020 0.028 0.036 0.044 - 0.012 0.024 0.035 0.047 0.060
CR - 0.770 0.600 0.400 0.250 0.170 * * * * * *
2 H012(t) 0.050 0.150 0.250 0.350 0.450 0.550 0.050 0.150 0.250 0.350 0.450 0.550
mean 0.050 0.151 0.249 0.348 0.447 0.546 0.052 0.156 0.261 0.364 0.469 0.572
ESD 0.004 0.011 0.018 0.028 0.036 0.048 0.004 0.013 0.021 0.029 0.036 0.049
CR 1.000 1.000 1.000 0.980 0.950 0.950 * * * * * *
H013(t) 0.075 0.225 0.425 0.625 0.825 1.025 0.075 0.225 0.425 0.625 0.825 1.025
mean 0.075 0.225 0.427 0.630 0.825 1.029 0.076 0.228 0.432 0.638 0.842 1.038
ESD 0.007 0.018 0.033 0.045 0.058 0.074 0.006 0.017 0.026 0.046 0.064 0.078
CR 0.940 0.940 0.940 0.950 0.930 0.950 * * * * * *
H023(t) 0.000 0.080 0.180 0.280 0.380 0.480 0.000 0.080 0.180 0.280 0.380 0.480
mean - 0.056 0.113 0.164 0.211 0.257 - 0.080 0.181 0.280 0.382 0.484
ESD - 0.010 0.019 0.026 0.033 0.039 - 0.013 0.027 0.042 0.056 0.072
CR - 0.320 0.100 0.020 0.020 0.010 * * * * * *
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